Toxic megacolon overview: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:


==Risk Factors==
==Risk Factors==
Common risk factors in the development of toxic negacolon include discontinuation of steroids, use of barium enemas, [[colonoscopy]], [[chemotherapy]], antidiarrheal drugs, anticholinergic drugs, [[narcotics]], Severe [[chronic obstructive pulmonary disease]], [[organ transplantation]], cardiothoracic procedures, [[diabetes mellitus]], [[immunosuppression]], [[renal failure]].


==Screening==
==Screening==

Revision as of 21:04, 27 November 2017

Toxic Megacolon Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Megacolon from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Abdominal X Ray

CT

Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic megacolon overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic megacolon overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic megacolon overview

CDC on Toxic megacolon overview

Toxic megacolon overview in the news

Blogs on Toxic megacolon overview

Directions to Hospitals Treating Toxic megacolon

Risk calculators and risk factors for Toxic megacolon overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Historical Perspective

Toxic megacolon was first discovered by Marshak and Lester in 1950. Jalen criteria was developed by Jalen et al to diagnose toxic megacolon in 1969.

Classification

There is no established system for the classification of toxic megacolon.

Pathophysiology

Toxic megacolon results from severe inflammation extending into the smooth-muscle layer and paralyses the colonic smooth muscle leading to dilatation. The extent of dilatation associated with the depth of inflammation and ulceration. Nitric oxide, an inhibitor of smooth-muscle tone, has an important role in the pathogenesis of toxic megacolon. Nitric oxide is produced by neutrophils and smooth-muscle cells in the inflamed colon.

Causes

The most common cause of toxic megacolon include inflammatory bowel disease and Clostridium difficile pseudomembranous colitis.

Differentiating ((Page name)) from Other Diseases

Epidemiology and Demographics

The precise incidence of toxic megacolon is unknown in general population. The incidence of toxic megacolon in the associated disorders including ulcerative colitis and Crohn's disease is 1000-2500 in 100,000 cases and 4400-6300 in 100,000 cases, respectively. The mortality rate of toxic megacolon associated with Clostridium difficile is approximately 38%-80%.

Risk Factors

Common risk factors in the development of toxic negacolon include discontinuation of steroids, use of barium enemas, colonoscopy, chemotherapy, antidiarrheal drugs, anticholinergic drugs, narcotics, Severe chronic obstructive pulmonary disease, organ transplantation, cardiothoracic procedures, diabetes mellitus, immunosuppression, renal failure.

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References


Template:WikiDoc Sources